Union Calendar No. 22
116th CONGRESS 1st Session |
[Report No. 116–44, Part I]
To provide that certain guidance related to waivers for State innovation under the Patient Protection and Affordable Care Act shall have no force or effect.
February 6, 2019
Ms. Kuster of New Hampshire (for herself, Mr. Beyer, and Mr. Courtney) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned
April 30, 2019
Additional sponsors: Mr. Welch, Ms. Schakowsky, Ms. Castor of Florida, Mr. Golden, Ms. Blunt Rochester, Mrs. Dingell, Mr. Kennedy, Mr. Rush, Mr. Ruiz, Mr. Pallone, Ms. Eshoo, Ms. Matsui, Mr. Van Drew, Ms. Clarke of New York, Ms. McCollum, Mr. Schrader, and Ms. Mucarsel-Powell
April 30, 2019
Reported from the Committee on Energy and Commerce
April 30, 2019
Committee on Ways and Means discharged; committed to the Committee of the Whole House on the State of the Union and ordered to be printed
To provide that certain guidance related to waivers for State innovation under the Patient Protection and Affordable Care Act shall have no force or effect.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
This Act may be cited as the “Protecting Americans with Preexisting Conditions Act of 2019”.
SEC. 2. Providing that certain guidance related to waivers for State innovation under the Patient Protection and Affordable Care Act shall have no force or effect.
Beginning April 1, 2019, the Secretary of Health and Human Services and the Secretary of the Treasury may not take any action to implement, enforce, or otherwise give effect to the guidance entitled “State Relief and Empowerment Waivers” (83 Fed. Reg. 53575 (October 24, 2018)), and the Secretaries may not promulgate any substantially similar guidance or rule.
Union Calendar No. 22 | |||||
| |||||
[Report No. 116–44, Part I] | |||||
A BILL | |||||
To provide that certain guidance related to waivers for State innovation under the Patient
Protection and Affordable Care Act shall have no force or effect. | |||||
April 30, 2019 | |||||
Reported from the Committee on Energy and Commerce | |||||
April 30, 2019 | |||||
Committee on Ways and Means discharged; committed to the Committee of the Whole House on the State of the Union and ordered to
be printed |